Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02149329
What this trial is testing

Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO

Who this might be right for
Febrile NeutropeniaHematological Malignancy
Amsterdam UMC, location VUmc 276
Large-scale testing (Phase 3)Active Not RecruitingNCT05883956
What this trial is testing

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelomonocytic, Chronic+1 more
Otsuka Australia Pharmaceutical Pty Ltd 13
Testing effectiveness (Phase 2)UnknownNCT01534702
What this trial is testing

Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML

Who this might be right for
Acute Myeloid Leukemia
Hannover Medical School 60
Large-scale testing (Phase 3)Study completedNCT00050531
What this trial is testing

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

Who this might be right for
Leukemia, Myeloid, Chronic
M.D. Anderson Cancer Center 94
Testing effectiveness (Phase 2)Study completedNCT00255346
What this trial is testing

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesAgnogenic Myeloid Metaplasia+5 more
M.D. Anderson Cancer Center 68
Testing effectiveness (Phase 2)Study completedNCT04436029
What this trial is testing

Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

Who this might be right for
Multiple Myeloma
Cartesian Therapeutics 5
Early research (Phase 1)Study completedNCT00482846
What this trial is testing

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

Who this might be right for
MucositisMultiple Myeloma
Barbara Ann Karmanos Cancer Institute 38
Early research (Phase 1)Active Not RecruitingNCT02153580
What this trial is testing

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

Who this might be right for
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin LymphomaB-Cell Prolymphocytic LeukemiaHigh Grade B-Cell Lymphoma, Not Otherwise Specified+10 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00292760
What this trial is testing

A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion

Who this might be right for
Chronic Lymphocytic Leukaemia
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)UnknownNCT02339350
What this trial is testing

Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children

Who this might be right for
Acute Lymphoblastic LeukemiaChild
The Korean Society of Pediatric Hematology Oncology 110
Early research (Phase 1)Study completedNCT03018223
What this trial is testing

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Who this might be right for
Non-Hodgkin's LymphomaAcute Leukemia in RemissionChronic Myeloid Leukemia+5 more
H. Lee Moffitt Cancer Center and Research Institute 32
Not applicableStudy completedNCT05517213
What this trial is testing

High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Affiliated Hospital to Academy of Military Medical Sciences 62
Testing effectiveness (Phase 2)Ended earlyNCT01222143
What this trial is testing

Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University Health Network, Toronto 12
Early research (Phase 1)Looking for participantsNCT06994676
What this trial is testing

CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Who this might be right for
High-risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia (CMML)AML - Acute Myeloid Leukemia+1 more
Crossbow Therapeutics, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00809276
What this trial is testing

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Who this might be right for
LymphomaMultiple MyelomaLeukemia+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Large-scale testing (Phase 3)Study completedNCT00891384
What this trial is testing

Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 194
Testing effectiveness (Phase 2)UnknownNCT04069208
What this trial is testing

IA14 Induction in Young Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Peking Union Medical College Hospital 42
Large-scale testing (Phase 3)Study completedNCT00474006
What this trial is testing

High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML

Who this might be right for
ACUTE MYELOGENOUS LEUKEMIA
Cooperative Study Group A for Hematology 398
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06429150
What this trial is testing

Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma

Who this might be right for
Multiple MyelomaPlasmacytoma
Shenzhen Geno-Immune Medical Institute 20
Early research (Phase 1)Study completedNCT01254578
What this trial is testing

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more
National Cancer Institute (NCI) 17
Next Page
37